Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer

Diagnostic and Interventional Radiology

Volumn 18, Issue 5, 2012, Pages 435-440

  Ceylan, Naim ^a   Doǧan, Sözen ^a   Kocaçelebi, Kenan ^b   Savaş, Recep ^a   Çakan, Alpaslan ^a   Çaǧrici, Ufuk ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Ege Saglik Hastanesi   (Turkey)

Author keywords

Lung cancer; Lymph node; Positron emission tomography and computed tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HILAR LYMPH NODE METASTASIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE METASTASIS; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INTRAOPERATIVE CARE; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM STAGING; PNEUMONECTOMY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866082090     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.4261/1305-3825.DIR.5100-11.2     Document Type: Article

References (23)

1. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005; 130:151-159.
2. Konishi J, Yamazaki K, Tsukamoto E, et al. Mediastinal lymph node staging by FDGPET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 2003; 70:500-506.
3. Bille A, Pelosi E, Skanjeti A, et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Eur J Cardiothorac Surg 2009; 36:440-445.
4. Shim SS, Lee KS, Kim BT, et al. Nonsmall cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005; 236:1011-1019.
5. Kim BT, Lee KS, Shim SS, et al. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT-a prospective study. Radiology 2006; 241:501-509.
6. Kim YK, Lee KS, Kim BT, et al. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer 2007; 109:1068-1077.
7. An YS, Sun JS, Park KJ, et al. Diagnostic performance of 18F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease. Lung 2008; 186: 327-336.
8. Higashi K, Ito K, Hiramatsu Y, et al. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study. J Nucl Med 2005; 46: 267-273.
9. Yi CA, Lee KS, Kim BT, et al. Efficacy of helical dynamic CT versus integrated PET/ CT for detection of mediastinal nodal metastasis in non-small cell lung cancer. AJR Am J Roentgenol 2007; 188:318-325.
10. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348:2500-2507.
11. Takamochi K, Yoshida J, Murakami K, et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung Cancer 2005; 47:235-242.
12. Antoch G, Stattaus J, Nemat AT, et al. Nonsmall cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229:526-533.
13. Shin KM, Lee KS, Shim YM, et al. FDG PET/CT and mediastinal nodal metastasis detection in stage T1 non-small cell lung cancer: prognostic implications. Korean J Radiol 2008; 9:481-489.
14. AJCC cancer staging manual. 6th ed. New York, NY: Springer, 2002; 165-177.
15. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111:1718-1723.
16. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET/CT compared with dedicated PET alone for the staging of patients with non-small cell lung cancer. Ann Thorac Surg 2004; 78:1017-1023.
17. Halpern BS, Schiepers C, Weber WA, et al. Presurgical staging of non-small cell lung cancer. Positron emission tomography, integrated positron emission tomography/ CT, and software image fusion. Chest 2005; 128:2289-2297.
18. Seely JM, Mayo JR, Miller RR, Muller NL. T1 lung cancer: prevalence of mediastinal lymph node metastases and diagnostic accuracy of CT. Radiology 1993; 186:129-132.
19. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202:441-446.
20. Von Haag DW, Follette DM, Roberts PF, Shelton D, Segel LD, Taylor T. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer. J Surg Res 2002; 103:160-164.
21. Takamochi K, Nagai K, Suzuki K, Yoshida J, Ohde Y, Nishiwaki Y. Clinical predictions of N2 disease in non-small cell lung cancer. Chest 2000; 117:1577-1582.
22. Nambu A, Kato S, Sato Y, et al. Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET. Ann Nucl Med 2009; 23:269-275.
23. Berghmans T, Dusart M, Paesmans M, et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDGPET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 2008; 3:6-12.